Effects of pioglitazone on cardiovascular events and all-cause mortality in patients with type 2 diabetes: A meta-analysis of randomized controlled trials
Mannucci E, Giaccari A, Gallo M, et al.
Nutr Metab Cardiovasc Dis. 2022;32(3):529-536.
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Effects of empagliflozin on markers of liver steatosis and fibrosis and their relationship to cardiorenal outcomes
Kahl S, Pernille Ofstad A, Zinman B, et al.
Diabetes Obes Metab. 2022 Feb 15.
Leggi
Upload and Review of Insulin Pump and Glucose Sensor Data by Adults with Type 1 Diabetes: A Clinic Audit
Kong YW, Venkatesh N, Paldus B et al
Diabetes Technol Ther. Pub. online 15 February 2022
Leggi
Diabetic ketoacidosis after initiation of sodium-glucose cotransporter inhibition under advanced hybrid closed-loop therapy in type 1 diabetes
Visser M, Mathieu C, Gillard P
Diabetes Technol Ther. Pub. online 14 February 2022
Leggi
Epigenome-wide association study of incident type 2 diabetes: a meta-analysis of five prospective European cohorts
Fraszczyk E, Spijkerman AMW, Snieder H, et al.
Diabetologia. Pub. online 15 February 2022.
Leggi
Effect of subcutaneous tirzepatide vs placebo added to titrated insulin glargine on glycemic control in patients with type 2 diabetes. The SURPASS-5 randomized clinical trial
Dahl D, Onishi Y, Norwood P, et al.
JAMA. 2022;327(6):534-545.
Leggi
Tirzepatide for patients with type 2 diabetes
Chipkin SR
JAMA. 2022;327(6):529-530.
Leggi
Comparative safety of sodium–glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors and sulfonylureas on the risk of diabetic ketoacidosis
Dawwas GK, Flory JH, Hennessy S et al.
Diabetes Care. 2022;dc212177
Leggi
Identifying suicidal risk in adolescents and young adults with type 1 diabetes: are depression screeners sufficient?
Moss AC, Robert AJ, Yi-Frazier JP, et al.
Diabetes Care. 2022;dc211553
Leggi
Data-driven subgroups of type 2 diabetes, metabolic response, and renal risk profile after bariatric surgery: a retrospective cohort study
Raverdy V, Cohen RV, Caiazzo R, et al.
Lancet Diabetes Endocrinol. 2022;S2213-8587(22)00005-5
Leggi